由D-(-)-核糖合成Aigialomycin D C2'—C7'片段的简捷方法

报道以D-(-)-核糖为起始原料合成Aigialomycin D的关键手性中间体C的一种简便方法. 化合物C是未见报道的新手性化合物.     

由D-(-)-核糖合成Aigialomycin D C2′～C7′片段的简捷方法

Aigialomycin D(1)是从海生红树林菌类Aigialus parvusBCC5311中分离出来的一种含18个碳原子的间二羟苯基大环内酯天然产物[1].该化合物具有较强的抗癌活性和抗疟疾活性.Aigialomycin D是一个间二苯酚与十四元环内酯相稠合的、含有3个手性中心和2个E-构型的双键化合物.其有意义     

Synthesis of diastereomeric,deoxy and ring-expanded sulfone analogues of aigialomycin D

Several analogues of the fungal natural product aigialomycin D (AmD) have been synthesised. These include the stereoisomer 5′R,6′S-AmD, 2,4-di-deoxyAmD, 1′,2′,7′,8′-tetrahydroAmD and a 15-membered macrocyclic sulfone. Growth inhibitory activities of these compounds against the HL-60 leukaemic cell line were measured. The ring-expanded sulfone and tetrahydro-analogue were found to have similar IC₅₀ values to the natural product, whereas the 5′R,6′S-stereoisomer was inactive. Energy minimisation of AmD and the synthesised analogues resulted in a range of lowest energy conformers, from planar, open arrangements of the macrocycle in AmD and tetrahydroAmD to bent, L-shaped structures for the sulfone. The synthesis of methyl orsellinate was investigated and optimised as part of this work. A stereodivergent route to both enantiomers of the diol fragment from d-ribose was also achieved.     

An efficient and practical total synthesis of aigialomycin D

An efficient and practical total synthesis of aigialomycin D 1 is described. This concise synthetic route features the use of readily available starting materials with the key transformations being the formation of the macrocycle by RCM under microwave irradiation conditions to effect complete E-selectivity, and regio- and stereospecific formation of the 1′,2′-double bond. The synthesis of aigialomycin D is achieved with the longest linear sequence of only 11 steps and an overall yield of 19%.     

Aigialomycins and related polyketide metabolites from the mangrove fungus Aigialus parvus BCC 5311

Reinvestigation of the secondary metabolites from the marine mangrove fungus Aigialus parvus BCC 5311 led to the isolation of six new nonaketide metabolites, aigialomycins F (4) and G (5a/5b), 7′,8′-dihydroaigialospirol (7), 4′-deoxy-7′,8′-dihydroaigialospirol (8), and rearranged macrolides 9 and 10, along with six previously described compounds, hypothemycin (1), aigialomycins A (2) and B (3), aigialospirol (6), 4-O-demethylhypothemycin (11), and aigialone (12). The structures of the new compounds were elucidated by analyses of the NMR spectroscopic and mass spectrometry data in combination with chemical means.